Elizabeth I. Pierpont, Ph.D. - Publications

University of Wisconsin, Madison, Madison, WI
language, reading

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 McNeill AM, Hudock RL, Foy AMH, Shanley R, Semrud-Clikeman M, Pierpont ME, Berry SA, Sommer K, Moertel CL, Pierpont EI. Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome. American Journal of Medical Genetics. Part A. PMID 31566897 DOI: 10.1002/Ajmg.A.61361  0.339
2019 Orchard PJ, Markowski TW, Higgins L, Raymond GV, Nascene DR, Miller WP, Pierpont EI, Lund TC. Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy. Scientific Reports. 9: 7858. PMID 31133696 DOI: 10.1038/S41598-019-44140-3  0.312
2018 Rosser TC, Edgin JO, Capone GT, Hamilton DR, Allen EG, Dooley KJ, Anand P, Strang JF, Armour AC, Frank-Crawford MA, Channell MM, Pierpont EI, Feingold E, Maslen CL, Reeves RH, et al. Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition Project. American Journal On Intellectual and Developmental Disabilities. 123: 514-528. PMID 30421968 DOI: 10.1352/1944-7558-123.6.514  0.421
2018 Pierpont EI, Hudock RL, Foy AM, Semrud-Clikeman M, Pierpont ME, Berry SA, Shanley R, Rubin N, Sommer K, Moertel CL. Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. Journal of Neurodevelopmental Disorders. 10: 21. PMID 29914349 DOI: 10.1186/S11689-018-9239-8  0.369
2018 Westenfield K, Sarafoglou K, Speltz LC, Pierpont EI, Steyermark J, Nascene D, Bower M, Pierpont ME. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report. Bmc Medical Genetics. 19: 100. PMID 29907092 DOI: 10.1186/S12881-018-0617-6  0.326
2018 Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, Raymond GV, Phelan R, Lund TC, Orchard PJ, Miller WP. Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy. Annals of Clinical and Translational Neurology. 5: 252-261. PMID 29560371 DOI: 10.1002/Acn3.526  0.329
2017 Edgin JO, Anand P, Rosser T, Pierpont EI, Figueroa C, Hamilton D, Huddleston L, Mason G, Spanò G, Toole L, Nguyen-Driver M, Capone G, Abbeduto L, Maslen C, Reeves RH, et al. The Arizona Cognitive Test Battery for Down Syndrome: Test-Retest Reliability and Practice Effects. American Journal On Intellectual and Developmental Disabilities. 122: 215-234. PMID 28452581 DOI: 10.1352/1944-7558-122.3.215  0.363
2016 Pierpont EI, Semrud-Clikeman M, Pierpont ME. Variability in clinical and neuropsychological features of individuals with MAP2K1 mutations. American Journal of Medical Genetics. Part A. PMID 27862862 DOI: 10.1002/Ajmg.A.38044  0.444
2016 Pierpont EI, Wolford M. Behavioral functioning in cardiofaciocutaneous syndrome: Risk factors and impact on parenting experience. American Journal of Medical Genetics. Part A. PMID 27149079 DOI: 10.1002/Ajmg.A.37725  0.335
2016 Pierpont E, Eisengart J, Ziegler R, Raymond G, Orchard PJ, Lund T, Miller WP. Neurocognitive Trajectory of Patients with Childhood Cerebral Adrenoleukodystrophy Who Received Allogeneic Hematopoietic Cell Transplantation at an Early Stage of Cerebral Disease Blood. 128: 4682-4682. DOI: 10.1182/Blood.V128.22.4682.4682  0.348
2015 Pierpont EI, Tworog-Dube E, Roberts AE. Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings. Developmental Medicine and Child Neurology. 57: 385-92. PMID 25366258 DOI: 10.1111/Dmcn.12621  0.366
2014 Pierpont ME, Magoulas PL, Adi S, Kavamura MI, Neri G, Noonan J, Pierpont EI, Reinker K, Roberts AE, Shankar S, Sullivan J, Wolford M, Conger B, Santa Cruz M, Rauen KA. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 134: e1149-62. PMID 25180280 DOI: 10.1542/Peds.2013-3189  0.335
2013 Kover ST, Pierpont EI, Kim JS, Brown WT, Abbeduto L. A neurodevelopmental perspective on the acquisition of nonverbal cognitive skills in adolescents with fragile X syndrome. Developmental Neuropsychology. 38: 445-60. PMID 24138215 DOI: 10.1080/87565641.2013.820305  0.394
2013 Pierpont EI, Tworog-Dube E, Roberts AE. Learning and memory in children with Noonan syndrome. American Journal of Medical Genetics. Part A. 161: 2250-7. PMID 23918208 DOI: 10.1002/Ajmg.A.36075  0.317
2011 Pierpont EI, Richmond EK, Abbeduto L, Kover ST, Brown WT. Contributions of phonological and verbal working memory to language development in adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 3: 335-47. PMID 21993552 DOI: 10.1007/S11689-011-9095-2  0.39
2010 Pierpont EI, Ellis Weismer S, Roberts AE, Tworog-Dube E, Pierpont ME, Mendelsohn NJ, Seidenberg MS. The language phenotype of children and adolescents with Noonan syndrome. Journal of Speech, Language, and Hearing Research : Jslhr. 53: 917-32. PMID 20543023 DOI: 10.1044/1092-4388(2009/09-0046)  0.542
2010 Pierpont EI, Pierpont ME, Mendelsohn NJ, Roberts AE, Tworog-Dube E, Rauen KA, Seidenberg MS. Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome. American Journal of Medical Genetics. Part A. 152: 591-600. PMID 20186801 DOI: 10.1002/Ajmg.A.33268  0.557
2009 Pierpont EI, Pierpont ME, Mendelsohn NJ, Roberts AE, Tworog-Dube E, Seidenberg MS. Genotype differences in cognitive functioning in Noonan syndrome. Genes, Brain, and Behavior. 8: 275-82. PMID 19077116 DOI: 10.1111/J.1601-183X.2008.00469.X  0.572
2005 Ullman MT, Pierpont EI. Specific language impairment is not specific to language: the procedural deficit hypothesis. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 41: 399-433. PMID 15871604 DOI: 10.1016/S0010-9452(08)70276-4  0.358
Show low-probability matches.